Literature DB >> 20617370

CD133(+) single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential.

Guangqiu Li1, Chao Liu, Jian Yuan, Xiaoqin Xiao, Na Tang, Junmei Hao, Hongwei Wang, Xiuwu Bian, Yongjian Deng, Yanqing Ding.   

Abstract

Single cell progenies (SCPs) inherit biological properties from their isogenetic mother cells. If a single cancer cell can give rise to progenies, which can be passaged sustainably in vitro and produce tumor in xenotransplantation, the cell should be cancer initiating cell. CD133 (Prominin-1, Prom1) is the marker of human colorectal cancer (CRC) stem cells and probably a marker of metastatic cancer stem cells (CSCs). Thirty-three SCPs of CRC cell line SW480 were isolated by limited dilution methods, thirty of which are CD133 positive and three negative. All of the CD133(+) SCPs are tumorigenic, and the subcutaneous tumors expanded rapidly, while only 1 of 3 CD133(-) SCPs developed a minimal tumor in nude mice. Orthotopic transplantation experiments showed that CD133(+) SCPs possessed heterogeneity in intestinal wall invasion, lymph node and liver metastases. CD133(+) SCPs varied in cell growth, invasive ability, epithelial-mesenchymal-transition and expression of CSCs markers (CD133, CD44, and CXCR4) associated with metastatic potential. CD133(-) SCPs did not produce secondary transplanted tumor, intestinal invasion and metastasis. The results indicated CD133(+) subpopulation of SW480 SCPs bear heterogeneous invasive and metastatic ability, and CRC-CSCs might be a heterogeous subpopulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20617370     DOI: 10.1007/s10585-010-9341-0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  44 in total

1.  Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth.

Authors:  Megumi Morimoto-Tomita; Yoshimi Ohashi; Azusa Matsubara; Makoto Tsuiji; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 2.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

3.  Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.

Authors:  Salvatore Pece; Daniela Tosoni; Stefano Confalonieri; Giovanni Mazzarol; Manuela Vecchi; Simona Ronzoni; Loris Bernard; Giuseppe Viale; Pier Giuseppe Pelicci; Pier Paolo Di Fiore
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

4.  The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.

Authors:  David Horst; Silvio K Scheel; Sibylle Liebmann; Jens Neumann; Susanne Maatz; Thomas Kirchner; Andreas Jung
Journal:  J Pathol       Date:  2009-12       Impact factor: 7.996

5.  Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.

Authors:  Hugo J Snippert; Johan H van Es; Maaike van den Born; Harry Begthel; Daniel E Stange; Nick Barker; Hans Clevers
Journal:  Gastroenterology       Date:  2009-03-24       Impact factor: 22.682

6.  A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis.

Authors:  Tobias Joyce; Daniela Cantarella; Claudio Isella; Enzo Medico; Alexander Pintzas
Journal:  Clin Exp Metastasis       Date:  2009-04-02       Impact factor: 5.150

7.  Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma.

Authors:  Dongho Choi; Hyo-Won Lee; Kyung-Yul Hur; Jae-Joon Kim; Gyeong-Sin Park; Si-Hyong Jang; Young-Soo Song; Ki-Seok Jang; Seung-Sam Paik
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

8.  A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer.

Authors:  Jun-Mei Hao; Juan-Zhi Chen; Hong-Mei Sui; Xue-Qing Si-Ma; Guang-Qiu Li; Chao Liu; Ji-Liang Li; Yan-Qing Ding; Jian-Ming Li
Journal:  J Pathol       Date:  2010-03       Impact factor: 7.996

9.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

10.  Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB.

Authors:  Chun-Yan Li; Bao-Xiu Li; Yi Liang; Rui-Qing Peng; Ya Ding; Da-Zhi Xu; Xin Zhang; Zhi-Zhong Pan; De-Sen Wan; Yi-Xin Zeng; Xiao-Feng Zhu; Xiao-Shi Zhang
Journal:  J Transl Med       Date:  2009-07-07       Impact factor: 5.531

View more
  14 in total

1.  Colorectal Cancer Stem Cells: Biology and Therapeutic Implications.

Authors:  Brian J Wilson; Tobias Schatton; Markus H Frank; Natasha Y Frank
Journal:  Curr Colorectal Cancer Rep       Date:  2011-06

2.  Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer.

Authors:  Kumiko Hongo; Shinsuke Kazama; Eiji Sunami; Nelson H Tsuno; Koki Takahashi; Hirokazu Nagawa; Joji Kitayama
Journal:  Med Oncol       Date:  2012-01-14       Impact factor: 3.064

3.  CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.

Authors:  Shan-shan Zhang; Zhi-peng Han; Ying-ying Jing; Shuang-fen Tao; Tie-jun Li; Hao Wang; Yang Wang; Rong Li; Yang Yang; Xue Zhao; Xiao-dong Xu; En-da Yu; Yao-cheng Rui; Hou-jia Liu; Li Zhang; Li-xin Wei
Journal:  BMC Med       Date:  2012-08-07       Impact factor: 8.775

4.  Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.

Authors:  Sharmila Shankar; Dara Nall; Su-Ni Tang; Daniel Meeker; Jenna Passarini; Jay Sharma; Rakesh K Srivastava
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

5.  Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.

Authors:  Riccardo Giampieri; Mario Scartozzi; Cristian Loretelli; Francesco Piva; Alessandra Mandolesi; Giovanni Lezoche; Michela Del Prete; Alessandro Bittoni; Luca Faloppi; Maristella Bianconi; Luca Cecchini; Mario Guerrieri; Italo Bearzi; Stefano Cascinu
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

6.  Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note.

Authors:  Mark I James; Lynne M Howells; Ankur Karmokar; Jennifer A Higgins; Peter Greaves; Hong Cai; Ashley Dennison; Matthew Metcalfe; Giuseppe Garcea; David M Lloyd; David P Berry; William P Steward; Karen Brown
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

7.  Drug treatment of cancer cell lines: a way to select for cancer stem cells?

Authors:  Ilaria Chiodi; Cristina Belgiovine; Francesca Donà; A Ivana Scovassi; Chiara Mondello
Journal:  Cancers (Basel)       Date:  2011-03-04       Impact factor: 6.639

Review 8.  Spelling Out CICs: A Multi-Organ Examination of the Contributions of Cancer Initiating Cells' Role in Tumor Progression.

Authors:  Shivani Baisiwala; Shreya Budhiraja; Chirag Goel; Khizar R Nandoliya; Miranda R Saathoff; Atique U Ahmed
Journal:  Stem Cell Rev Rep       Date:  2021-07-09       Impact factor: 6.692

9.  A modified method for isolation of bladder cancer stem cells from a MB49 murine cell line.

Authors:  Yong-tong Zhu; Cheng-yong Lei; Yang Luo; Na Liu; Cheng-wu He; Wei Chen; Fei Li; Yong-jian Deng; Wan-long Tan
Journal:  BMC Urol       Date:  2013-11-04       Impact factor: 2.264

Review 10.  Cancer stem cells and tumor metastasis (Review).

Authors:  Shuang Li; Qin Li
Journal:  Int J Oncol       Date:  2014-04-02       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.